Lifestyle important as drugs in type-2 diabetes

Lifestyle interventions may be as effective as drug therapy at preventing type-2 diabetes in patients with impaired glucose tolerance (IGT), research suggests.

Follow-up data from the Finnish Diabetes Prevention Study showed a four-year intensive lifestyle intervention reduced the risk of type-2 diabetes by 43 per cent. During active intervention, the risk of type-2 diabetes was cut by 58 per cent.  

This contrasts with the DREAM study data which showed that 8mg daily rosiglitazone for three years in addition to lifestyle interventions reduced the risk of patients with IGT or impaired fasting glucose transferring to type-2 diabetes by 60 per cent.  

County Down GP Dr Colin Kenny, chairman of the Primary Care Diabetes Society, said: ‘Exercise intervention is an effective intervention.’ However, he added: ‘The intervention is quite intensive and would be much harder to transfer into the NHS.’ 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...